India, Oct. 27 -- The shares of the company that develops, manufactures, and markets pharmaceutical formulations in various acute and chronic therapeutic areas and several consumer healthcare products are in the spotlight after they rose by 10 per cent in today's market session following its Q2 results, where exports rose by 33%.

With a market capitalisation of Rs. 1,03,924 cr, the shares of Mankind Pharma Ltd were trading at Rs. 2514.05 per share, making an intraday high of Rs. 2,521.30, up by 10% from its previous close of Rs. 2,302 per share.

Financial Performance: Revenue Growth Accelerates Profitability Mankind Pharma registered healthy performance in Q2 of FY27, with the company's income from operations witnessing a YoY rise of...